Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression.

Gieira S JonesKatherine A HoadleyHalei BenefieldLinnea T OlssonAlina M HamiltonArjun BhattacharyaErin L KirkHeather J TipaldosJodie M FlemingKevin P WilliamsMichael I LoveHazel B NicholsAndrew F OlshanMelissa A Troester

Published in: Breast cancer research and treatment (2022)

This multi-gene HGF signature is a poor-prognosis feature for breast cancer and may identify patients who could benefit from HGF-targeted treatments, an unmet need for Black and triple-negative patients.

Keyphrases

poor prognosis
growth factor
long non coding rna
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
gene expression
cancer therapy
copy number
metabolic syndrome
young adults
insulin resistance
adipose tissue
skeletal muscle
patient reported